18F-DOPA vs. 18F-FDG PET/CT in the ectopic ACTH syndrome due to pulmonary carcinoid tumor

Endocrinol Nutr. 2015 Apr;62(4):202-4. doi: 10.1016/j.endonu.2015.01.006. Epub 2015 Feb 25.

Authors

Irene Acevedo-Báñez¹, Juan Luis Tirado-Hospital¹, Ovidio Muñiz-Grijalvo², Miguel Angel Mangas-Cruz³, Francisco Javier García-Gómez⁴

Affiliations

¹ Department of Nuclear Medicine, Virgen del Rocío Universitary Hospital, Seville, Spain.
² Department of Internal Medicine, Virgen del Rocío Universitary Hospital, Seville, Spain.
³ Department of Endocrinology, Virgen del Rocío Universitary Hospital, Seville, Spain.
⁴ Department of Nuclear Medicine, Virgen del Rocío Universitary Hospital, Seville, Spain. Electronic address: javier191185@gmail.com.

PMID: 25726370
DOI: 10.1016/j.endonu.2015.01.006

No abstract available

Publication types

Case Reports
Comparative Study

MeSH terms

ACTH Syndrome, Ectopic / diagnostic imaging*
ACTH Syndrome, Ectopic / etiology
Adult
Carcinoid Tumor / complications
Carcinoid Tumor / diagnostic imaging*
Dihydroxyphenylalanine / analogs & derivatives
Fluorine Radioisotopes
Fluorodeoxyglucose F18
Humans
Lung Neoplasms / complications
Lung Neoplasms / diagnostic imaging*
Male
Pituitary ACTH Hypersecretion / complications
Positron Emission Tomography Computed Tomography*
Radiopharmaceuticals

Substances

Fluorine Radioisotopes
Radiopharmaceuticals
Fluorodeoxyglucose F18
fluorodopa F 18
Dihydroxyphenylalanine